These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 209021)

  • 1. Degradation of receptor-bound human choriogonadotropin by murine Leydig tumor cells.
    Ascoli M; Puett D
    J Biol Chem; 1978 Jul; 253(14):4892-9. PubMed ID: 209021
    [No Abstract]   [Full Text] [Related]  

  • 2. Degradation of the subunits of receptor-bound human choriogonadotropin by Leydig tumor cells.
    Ascoli M
    Biochim Biophys Acta; 1980 May; 629(2):409-17. PubMed ID: 6248122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gonadotropin binding and stimulation of steroidogenesis in Leydig tumor cells.
    Ascoli M; Puett D
    Proc Natl Acad Sci U S A; 1978 Jan; 75(1):99-102. PubMed ID: 203945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the degradation of receptor-bound human choriogonadotropin by leupeptin.
    Ascoli M
    Biochim Biophys Acta; 1979 Sep; 586(3):608-14. PubMed ID: 224947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Removal of the surface-bound human choriogonadotropin results in the cessation of hormonal responses in cultured Leydig tumor cells.
    Segaloff DL; Ascoli M
    J Biol Chem; 1981 Nov; 256(22):11420-3. PubMed ID: 6271747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of gonadotropin receptors in a murine Leydig tumor cell line.
    Rebois RV; Fishman PH
    J Biol Chem; 1984 Mar; 259(5):3096-101. PubMed ID: 6199355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demonstration of a direct effect of inhibitors of the degradation of receptor-bound human choriogonadotropin on the steroidogenic pathway.
    Ascoli M
    J Biol Chem; 1978 Nov; 253(21):7839-43. PubMed ID: 212439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Internalization and degradation of receptor-bound human choriogonadotropin in Leydig tumor cells. Fate of the hormone subunits.
    Ascoli M
    J Biol Chem; 1982 Nov; 257(22):13306-11. PubMed ID: 6292185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of hypocholesterolemia and chronic hormonal stimulation on sterol and steroid metabolism in a Leydig cell tumor.
    Ascoli M
    J Lipid Res; 1981 Nov; 22(8):1247-53. PubMed ID: 7320635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progesterone action in a murine Leydig tumor cell line (mLTC-1), possibly through a nonclassical receptor type.
    El-Hefnawy T; Manna PR; Luconi M; Baldi E; Slotte JP; Huhtaniemi I
    Endocrinology; 2000 Jan; 141(1):247-55. PubMed ID: 10614645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the degradation of receptor-bound human choriogonadotropin by lysosomotropic agents, protease inhibitors, and metabolic inhibitors.
    Ascoli M; Puett D
    J Biol Chem; 1978 Nov; 253(21):7832-8. PubMed ID: 212438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor-mediated uptake and degradation of human chorionic gonadotropin: fate of the hormone subunits.
    Ascoli M
    Ann N Y Acad Sci; 1982; 383():151-73. PubMed ID: 6283988
    [No Abstract]   [Full Text] [Related]  

  • 13. Complete dissociation of gonadotropin receptor binding and signal transduction in mouse Leydig tumour cells. Obligatory role of glycosylation in hormone action.
    Sairam MR
    Biochem J; 1990 Feb; 265(3):667-74. PubMed ID: 2306206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dynamics of the steroidogenic response of perifused Leydig tumor cells to human chorionic gonadotropin, ovine luteinizing hormone, cholera toxin, and adenosine 3',5'-cyclic monophosphate.
    Segaloff DL; Puett D; Ascoli M
    Endocrinology; 1981 Feb; 108(2):632-8. PubMed ID: 6256160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inhibition of progesterone secretion and the regulation of cyclic nucleotides by atrial natriuretic factor in gonadotropin responsive murine Leydig tumor cells.
    Pandey KN; Kovacs WJ; Inagami T
    Biochem Biophys Res Commun; 1985 Dec; 133(2):800-6. PubMed ID: 3002360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal induction of specific protein synthesis in murine Leydig tumor cells.
    Melner MH; Puett D
    Biochem Int; 1985 May; 10(5):763-70. PubMed ID: 3874624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase in testis luteinizing hormone receptor by estrogen in mice susceptible to Leydig cell tumors.
    Navickis RJ; Shimkin MB; Hsueh AJ
    Cancer Res; 1981 May; 41(5):1646-51. PubMed ID: 6260347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lutropin receptors in normal and tumour Leydig cells.
    Cooke BA; Dix CJ; Magee-Brown R
    Biochem Soc Trans; 1981 Feb; 9(1):40-2. PubMed ID: 6260554
    [No Abstract]   [Full Text] [Related]  

  • 19. Testicular LH receptors during aging in Fisher 344 rats.
    Amador A; Steger RW; Bartke A; Johns A; Siler-Khodr TM; Parker CR; Shepherd AM
    J Androl; 1985; 6(1):61-4. PubMed ID: 2982778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of estrogen receptors in various mouse Leydig cell tumor lines.
    Sato B; Huseby RA; Samuels LT
    Cancer Res; 1978 Sep; 38(9):2842-7. PubMed ID: 679191
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.